Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
Weight loss drugs double risk of wet AMD in diabetes patients
Published on June 11, 2025
Canadian researchers find that taking semaglutide increases the chances of developing neovascular age-related macular degeneration among those with diabetes
Continue reading on website
Other news
EssilorLuxottica slated to acquire Optegra clinics
June 11, 2025
The ophthalmology platform Optegra operates more than 70 eye hospitals and diagnostic facilities in 5 European markets.
Individualizing optometry care to all patient populations
June 11, 2025
Bryce St. Clair, OD, MPH, authors the June edition of the Cultural Responsiveness Blog, and urges doctors to consider cultural and socioeconomic backgrounds when caring for patients.
Weight loss drugs double risk of wet AMD in diabetes patients | Edcetera - Optometry